Human CSH2/CS-2/CSB ORF/cDNA clone-Lentivirus particle (NM_020991)
Cat. No.: vGMLP002297
Pre-made Human CSH2/CS-2/CSB Lentiviral expression plasmid for CSH2 lentivirus packaging, CSH2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
Placental lactogen/CSH2/CSH2/CS-2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP002297 | Human CSH2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP002297 |
Gene Name | CSH2 |
Accession Number | NM_020991 |
Gene ID | 1443 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 654 bp |
Gene Alias | CS-2,CSB,GHB1,hCS-B,PL |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCTGCAGGCTCCCGGACGTCCCTGCTCCTGGCTTTTGCCCTGCTCTGCCTGCCCTGGCTTCAAGAGGCTGGTGCCGTCCAAACCGTTCCGTTATCCAGGCTTTTTGACCACGCTATGCTCCAAGCCCATCGCGCGCACCAGCTGGCCATTGACACCTACCAGGAGTTTGAAGAAACCTATATCCCAAAGGACCAGAAGTATTCATTCCTGCATGACTCCCAGACCTCCTTCTGCTTCTCAGACTCTATTCCGACACCCTCCAACATGGAGGAAACGCAACAGAAATCCAATCTAGAGCTGCTCCGCATCTCCCTGCTGCTCATCGAGTCGTGGCTGGAGCCCGTGCGGTTCCTCAGGAGTATGTTCGCCAACAACCTGGTGTATGACACCTCGGACAGCGATGACTATCACCTCCTAAAGGACCTAGAGGAAGGCATCCAAACGCTGATGGGGAGGCTGGAAGACGGCAGCCGCCGGACTGGGCAGATCCTCAAGCAGACCTACAGCAAGTTTGACACAAACTCACACAACCATGACGCACTGCTCAAGAACTACGGGCTGCTCTACTGCTTCAGGAAGGACATGGACAAGGTCGAGACATTCCTGCGCATGGTGCAGTGCCGCTCTGTAGAGGGTAGCTGTGGCTTCTAG |
ORF Protein Sequence | MAAGSRTSLLLAFALLCLPWLQEAGAVQTVPLSRLFDHAMLQAHRAHQLAIDTYQEFEETYIPKDQKYSFLHDSQTSFCFSDSIPTPSNMEETQQKSNLELLRISLLLIESWLEPVRFLRSMFANNLVYDTSDSDDYHLLKDLEEGIQTLMGRLEDGSRRTGQILKQTYSKFDTNSHNHDALLKNYGLLYCFRKDMDKVETFLRMVQCRSVEGSCGF |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-SE0827-Ab | Anti-CSH2/ CS-2/ CSB functional antibody |
Target Antigen | GM-Tg-g-SE0827-Ag | CSH2 protein |
ORF Viral Vector | pGMLP002297 | Human CSH2 Lentivirus plasmid |
ORF Viral Vector | pGMLV002681 | Human CSH2 Lentivirus plasmid |
ORF Viral Vector | vGMLP002297 | Human CSH2 Lentivirus particle |
ORF Viral Vector | vGMLV002681 | Human CSH2 Lentivirus particle |
Target information
Target ID | GM-SE0827 |
Target Name | Placental lactogen/CSH2 |
Gene Group Identifier (Target Gene ID in Homo species) |
1443 |
Gene ID | 1443 (Homo sapiens) |
Gene Symbols & Synonyms | CSH2,PL,CSB,CS-2,GHB1,hCS-B |
Target Alternative Names | Placental lactogen, CSH2,Chorionic somatomammotropin hormone 2,Choriomammotropin,Lactogen, Placental lactogen (PL),PL,CSB,CS-2,GHB1,hCS-B |
Uniprot Accession |
P0DML3
Additional SwissProt Accessions: P0DML3 |
Uniprot Entry Name | |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | |
Disease from KEGG | Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Growth hormone synthesis, secretion and action |
Gene Ensembl | ENSG00000213218 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.